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Abstract  
Interventions developed to improve disability outcomes for low back pain (LBP) often show 
only small effects. Mediation analysis was used to investigate what led to the effectiveness 
of the STarT Back trial, a large primary care-based trial which treated patients consulting 
with LBP according to their risk of a poor outcome. The high-risk subgroup, randomised to 
receive either psychologically-informed physiotherapy (n=93) or current best care (n=45), 
were investigated to explore pain-related distress and pain intensity as potential mediators 
of the relationship between treatment allocation and change in disability. Structural 
equation modelling was used to generate latent variables of pain-related distress and pain 
intensity from measures used to identify patients at high-risk (fear-avoidance beliefs, 
depression, anxiety and catastrophising thoughts). Outcome was measured using the 
Roland-Morris Disability Questionnaire. Change in pain-related distress and pain intensity 
were found to have a significant mediating effect of 0.25 (standardised estimate, 
bootstrapped 95% CI 0.09 to 0.39) on the relationship between treatment group allocation 
and change in disability outcome. This study adds to the evidence base of treatment 
mediation studies in pain research and the role of distress in influencing disability outcome 
in those with complex LBP. 
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Perspective 
 
Mediation analysis using structural equation modelling found that change in pain-related 
distress and pain intensity mediated treatment effect in the STarT Back trial. This type of 
analysis can be used to gain further insight into how interventions work, and lead to the 
design of more effective interventions in future. 
 
Key words: 
Mediation analysis; Low back pain; Psychological intervention 
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Introduction 
Low back pain (LBP) has a global point prevalence of 9.4% and prevalence of 15% in Western 
European countries [21]. In the UK, LBP has been found to be the most common reason for 
patients consulting their general practitioner (GP) [23]. LBP has a wide impact, not only on 
the sufferer but also on healthcare costs [22,31,33], workplace absence [31,54] and social 
support [33]. While the prognosis of many patients who consult with LBP is good [34,37], 
there is variation amongst individuals and longer-term problems with pain and disability are 
often reported up to a year after consultation [16,34]. Identifying factors which are 
associated with long-term disability has been the focus of recent research, and evidence has 
been found for a number of psychological factors being predictive of outcome (e.g. fear-
avoidance beliefs [27,38], catastrophising thoughts [13] and depression [13,27]).  
 
Treatments to improve disability by targeting these factors, such as cognitive-behavioural 
therapy (CBT), have been shown to be successful in secondary care populations [9,20] but 
mixed results have been found in primary care populations, possibly due to the more 
heterogeneous population and the less intensive psychological interventions provided [52]. 
One potential solution that has been recently explored is the idea of providing stratified 
care based on a person’s risk of a poor outcome. A key example of this, the STarT Back 
approach [19], was found to be effective at reducing disability when patients consulting 
primary care for LBP were assessed for their risk of a poor outcome and matched to an 
intervention based on their risk profile. Patients with the most complex problems (a score of 
four or more on the tool, with this score incorporating four or more items on a psychological 
subscale) received specialised, psychologically informed physiotherapy treatment to address 
these factors. However, although the factors chosen to help stratify patients were known 
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prognostic factors, this does not necessarily mean that these same factors were also strong 
targets for treatment in this group, i.e. were mediating factors.  
 
The purpose of this study was to investigate if the psychological factors used to stratify 
patients into the high-risk group mediated treatment outcomes in patients who were then 
given treatment designed to address those factors. Because mediators help explain how 
treatment achieves its effect and identify factors that can be modified by treatment [29], 
such an analysis of the STarT Back high-risk group would allow us to test the hypothesis that 
these psychological factors were indeed associated with the effectiveness of the treatment 
at  four-month follow-up.  
 
 
Methods 
 
STarT Back trial 
The STarT Back trial [ISRCTN37113406] was a randomised controlled trial (RCT) that 
compared stratified care with current best care in primary care patients consulting with LBP 
[19]. At baseline, 851 patients were randomised (568 to intervention and 283 to control), 
with a mean age of 50 years (SD 14.8). Of this population 58.8% were female and 41.2% 
were male. In the high-risk group specifically, the mean age was slightly higher (54 years, SD 
12.88) and a slightly lower percentage were female (56.5%). Pain duration in this group was 
reported as Less than one month (15.9%); 1-3 months (20.3%); 4-6 months (16.7%); 7 
months-3 years (21.7%); and More than 3 years (25.4%). Patients were included in the trial if 
they were aged 18 years or over, could speak English and had LBP of any duration, with or 
without associated radiculopathy. Patients were excluded if their pain was potentially 
indicative of a serious disorder (e.g. cancer), if they had serious comorbidities that would 
negatively impact treatment (e.g. schizophrenia), were pregnant or were undergoing other 
forms of treatment [19]. If patients were assigned to stratified care, treatment was matched 
to the patient’s prognostic risk using a brief prognostic index, the Keele STarT Back tool [18], 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 
 
which consisted of nine questions relating to eight physical and psychological factors known 
to be predictive of persistent LBP-related disability. Scores on both the overall tool score 
and a five-item psychological subscale score allocated patients to low-, medium- or high-risk 
targeted treatment groups. A score of four or more on the psychological subscale 
specifically indicated the presence of symptoms of pain-related distress, meaning the 
patient was typically more complex to treat and therefore at higher risk of a poor treatment 
outcome. These high-risk patients went on to receive psychologically informed 
physiotherapy [30] delivered by physiotherapists who had undergone six days of training 
sessions focused on skills to help them address psychosocial barriers to recovery. The 
psychological factors discussed as part of this training included those measured in the STarT 
Back Tool such as fear-avoidance beliefs, catastrophising thoughts, anxiety and depression. 
However, although the high-risk training was based on a cognitive-behavioural framework, 
the training did not constitute full-blown cognitive-behaviour therapy (which would have 
required much more intensive training), but aimed to establish psychologically informed 
practice (PIP), where physiotherapists felt confident to address patients’ unhelpful beliefs, 
emotions and behavioural responses to pain [30]. The individual psychological constructs 
identified by the STarT Back tool were therefore not systematically addressed, but instead 
addressed as and when they presented in a patient. Therapists were given skills to reduce 
pain-related distress through clear communication, reassurance and activity promotion in 
order to improve physical function. It therefore seemed appropriate to test whether the 
treatment effect on physical function was mediated by changes in overall pain-related 
distress rather than through individual psychological factors. Ethical approval and 
informed consent from study participants was gained in the original study and 
additional consent was therefore not required for the present study. 
 
 
Measures 
Low back pain-specific disability 
The primary outcome in the STarT Back trial was back pain disability at 12 months measured 
by the Roland-Morris Disability Questionnaire (RMDQ) [40]. In the present study, RMDQ 
score at baseline and four-month follow-up was included. The RMDQ is a LBP-specific 
measure comprised of a list of 24 statements related to the ability to carry out movements 
or everyday activities. Higher scores indicate greater back pain-related disability. The RMDQ 
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has been found to have good psychometric properties overall in LBP populations 
[15,36,39,40,44,47].  
 
Pain-related distress 
The psychological variables included in the screening tool for which full measures were 
available were included as potential mediators: catastrophising (Pain Catastrophising Scale, 
PCS [49]), fear-avoidance beliefs (Tampa Scale for Kinesiophobia, TSK [25]) and anxiety and 
depression (Hospital Anxiety and Depression Scale, HADS [55]). Each of these measures 
captured an aspect of pain-related distress, which was tested via factor analysis (see 
Supplement 1). The PCS is made up of 13 items each scored on a five-point Likert scale, with 
a higher total score signifying higher pain catastrophising. The 17-item, unidimensional 
version of the TSK was used in the STarT Back study. A higher score on this measure 
indicates more severe fear-avoidance beliefs. The HADS contains 14 items, with seven items 
each for anxiety and depression. These are scored on a four-point Likert scale, with a higher 
score indicating higher anxiety and/or depression. Each of the measures are used frequently 
in primary care musculoskeletal research, and have been shown to have good measurement 
properties in this population (e.g. [4,8,53]). There is some debate about the psychometric 
properties of the TSK, including its factor structure (see [11,28] for reviews), but use of the 
TSK as a unidimensional tool is common. Within the present population, all of the measures 
were found to have good internal consistency with baseline Cronbach’s alpha values of 
above 0.70 (0.94 for the PCS; 0.73 for the TSK; 0.82 and 0.85 for the HADS subscales of 
anxiety and depression respectively).  
 
Pain intensity 
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Pain intensity is often used as an outcome measure but is also known to have an important 
role in other patient outcomes [35] and is also strongly related to psychological factors [51]. 
In the original STarT Back trial [19], pain intensity was not specifically the focus of the high-
risk intervention, but in primary care settings where many patients consult with 
musculoskeletal pain, pain is often the focus of treatment. This variable was therefore 
examined as an additional potential mediating factor alongside the psychological factors. 
Three measures of pain intensity were available in the STarT Back dataset; least pain over 
the last two weeks, average pain over the last two weeks and pain intensity on the day the 
questionnaire was completed. Each of the variables were measured on an 11-point Likert 
scale, with a higher score indicating higher pain intensity. 
 
 
Mediation analysis using Structural Equation Modelling (SEM) 
Mediation analysis was carried out using structural equation modelling (SEM), which 
combines linear regression and factor analysis [50] and maps out the paths between 
observed and unobserved variables and the error associated with each variable [5]. SEM is a 
useful technique for performing mediation analysis as it accounts for error in the observed 
variables and can test more complex models than traditional regression techniques. This 
type of analysis requires multiple variables or items per factor (latent variable), which allows 
the factor to be measured with greater reliability [1,48].  
 
Statistical analysis 
The analysis of mediating factors is complex and a number of steps were required in order 
to conduct this analysis, which are set out below. All analyses were conducted using SPSS 
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PASW statistics package version 18 and AMOS (add-on statistics package to SPSS) version 
19. 
 
Descriptive statistics (means and standard deviations (SDs)) were calculated for baseline and 
four-month follow-up for the outcome and potential mediator variables for each of the 
three prognostic subgroups, and distributions checked for normality as this is an assumption 
underlying all of the analyses. Descriptive statistics were also used to examine baseline 
characteristics of participants responding versus not responding at four-month follow-up.  
 
Creation of residualised change scores 
Because change was of interest in the present analysis, residualised change scores were 
calculated for each of the potential mediator and outcome variables. Residualised change 
scores represent the difference between the score at follow-up compared to what was 
predicted at baseline [47], thereby controlling for baseline score. Residualised change scores 
are frequently used in studies of mediation (e.g. [14,42]) and are calculated by running a 
linear regression with the follow-up score as the outcome and the baseline score as the 
predictor, and saving the residual values (difference between the observed value at follow-
up and the value predicted at baseline) which were then used in all subsequent analyses. 
 
Testing criteria for potential mediation 
In order for a variable to be a potential mediator of outcome, it must be potentially 
modifiable (i.e. change over time) and it must be associated with both treatment and 
outcome (the a and b paths in Figure 1). To examine modifiability, the absolute change that 
occurred between baseline and four-month follow-up was calculated and examined. To 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
examine the associations on the a and b paths, linear regression analyses were performed 
to investigate the relationships between treatment group allocation (intervention or 
control) and residualised change in each of the potential mediators, and between 
residualised change in each of the potential mediators and residualised change in outcome. 
  
Creation of latent variables 
In order to create latent variables to be used in the SEM, exploratory factor analysis (EFA) 
and subsequently confirmatory factor analysis (CFA) were conducted with the four 
psychological mediators to see if the different measures represented a single ‘pain-related 
distress’ factor, and an EFA was also conducted on the pain intensity measures to see if they 
represented a single factor of ‘low back pain’. In SEM, relationships between variables of 
interest must be tested to ensure they are correctly specified to have (or not have) a 
relationship in the model [41]. CFA was therefore also used to confirm whether the two 
latent variables of pain-related distress and low back pain were representative of distinct 
latent variables. A strong correlation (i.e. 0.60 or above) would need to be acknowledged in 
the model by means of a double-headed arrow to show co-variance.  
 
The factor analyses were performed on the entire STarT Back sample rather than only the 
high-risk group reported in this paper, and are not reported fully here (see Supplementary 
Section 1 for a summary of the results). This was to ensure that the number of cases was 
adequate for factor analysis to be performed. The mediation analysis was only performed 
on the high-risk group. 
 
Mediation analysis 
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The statistical interpretation of mediation analysis can be broken down into separate effects 
(see Figure 1). The c path is the direct effect of treatment on outcome, before taking into 
account the effects of specific mediating variables. Paths a and b make up the mediating 
pathway, with the mediating effect usually being described in the literature as the product 
of coefficients (ab) [29]. The ć path denotes the total effect of the whole model (ab+c). SEM 
provides the product of coefficients of the mediating effect with bias-corrected 
bootstrapped CIs, which is currently seen as an optimal way of performing mediation 
analysis [12,17]. 1,000 bias-corrected bootstrapped samples and 95% CIs were used in the 
present analysis. Complete case data was used for this analysis because the bias-corrected 
CIs can only be generated with complete data, but a sensitivity analysis using all available 
data (Full Information Maximum Likelihood, FIML) (n=236) was also conducted as a 
comparison (see Appendix 1). 
The following goodness-of-fit indices were used to assess how well the proposed model 
fitted the available data:  X
2
 statistic, X
2
/df, Comparative Fit Index (CFI), Root Mean Square 
Error of Approximation (RMSEA) and Standardised Root Mean square Residual (SRMR) [3,5]. 
Good or adequate model fit is indicated by a non-significant X
2
 value, a X
2
/df of between 2 
and 5, a CFI of 0.95 or above and RMSEA and SRMR values of 0.08 or above. No one fit index 
is seen as superior, and it is therefore recommended that judgement of fit is based on the 
overall assessment of several indices (Byrne 2008).  
 
 
Results 
Testing criteria for potential mediation 
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Table 1 contains mean scores at baseline and mean change at four-month follow-up for all 
of the potential mediator variables. There was a difference between the amounts of change 
in potential mediators observed in the treatment groups at four-month follow-up compared 
to the control group, including a 4.4 point difference in change for catastrophising thoughts 
and a 5.8 point difference in change for fear-avoidance beliefs, representing the largest 
changes. The SDs for all mediators were quite large, suggesting large variability in change 
within the high-risk group. Tests for normality (skewness and kurtosis values, histograms 
and p-plots) indicated some departure from normality with values above 1.0 for several 
variables. 
 
After calculating residualised change scores, linear regression analyses for each of the 
potential mediator variables with disability outcome were performed (Table 2). The results 
indicated that in the treatment group, residualised change in the psychological variables 
strongly predicted residualised change in RMDQ, accounting for 25% to 39% of the variance 
in this outcome. Residualised change in the pain variables were shown to be stronger 
predictors; they accounted for between 51% and 63% of the variance of residualised change 
in RMDQ. In the control group, residualised change in all potential mediators also accounted 
for a large amount of variance of residualised change in RMDQ. This showed support for the 
psychological factors as well as the pain variables to potentially mediate treatment 
outcome, as these variables do show change over time and are associated with outcome (b 
path). 
 
Finally, it was important to also test the a path, or the relationship between treatment 
allocation and residualised change in each of the potential mediators. If the treatment had 
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little effect on the potential mediating variables then the variables are unlikely to be the 
mechanism through which the treatment was successful. The results in Table 3 show that a 
small proportion of variance (between 2 and 12%) of residualised change was explained by 
treatment allocation (stratified care versus control) for each of the potential mediators. For 
residualised change in anxiety in particular, the association was very weak and not 
statistically significant, as indicated by the 95% CI. The results indicated that treatment 
allocation had the strongest association with residualised change in fear-avoidance beliefs. 
 
In summary, these preliminary analyses show support for both the psychological and pain 
variables to be potential mediators of the effects of the high-risk treatment. The variables 
changed significantly between baseline and follow-up, and were associated with 
residualised change in outcome (disability).  Allocation to the high-risk treatment arm was 
found to be predictive of residualised change in all of the potential mediator variables, with 
the exception of anxiety. The EFA and CFA (Supplementary Section 1) confirmed that the 
four psychological factors were representative of a pain-related distress latent variable, 
which was distinct from a pain intensity latent variable represented by three pain measures. 
However the two latent variables were found to be strongly correlated. These variables 
were therefore taken forward as planned as mediating pathways of the relationship 
between treatment allocation and residualised change in functional outcome.
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Mediation analysis 
The mediation model for residualised change in pain-related distress and pain intensity as 
mediators of the relationship between allocation to the high-risk STarT Back treatment and 
residualised change in disability is shown in Figure 1. The strong correlation found between 
the latent variables of pain-related distress and pain intensity is represented by an arrow 
indicating covariance. Considering all model fit statistics the model was judged to provide 
adequate fit to the data  (X
2
=54.36(23), p<0.05, X
2
/df=2.36, CFI=0.96, RMSEA=0.10 (95% 
CI=0.07 to 0.13), SRMR=0.05).  
 
The a path in this model is interpreted as an average treatment effect, due to the treatment 
allocation variable being binary (control = 0) [10]. The value of 0.27 for the a path between 
treatment allocation and pain-related distress therefore can be interpreted as the change in 
pain-related distress between baseline and four-month follow-up being 0.27 units higher in 
the treatment group than in the control group (a larger change). Similarly, the b path of 0.40 
can be interpreted as that a 1 unit change in pain-related distress leads to a 0.40 change in 
disability. The effects of the model (see Table 4) show that the total effect (ć) of the model is 
0.30. Once the mediator variables (combined for pain-related distress and low back pain) 
were added to the model the ab pathway explained a considerable proportion of the 
treatment effect; a statistically significant mediating effect of change in the latent variables 
was found (standardised indirect effect 0.25, bootstrapped 95% CI 0.09 to 0.39). 
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The sensitivity analysis using all available data resulted in weaker coefficients for the a and c 
paths (0.04 and 0.20 respectively) compared to the complete case analysis (0.27 and 0.27 
respectively), and a very small total effect (-0.02) was found compared to the total effect of 
0.30 in the complete case analysis. These results suggest that those who did not respond at 
follow-up were different to those who responded, in that they experienced a smaller change 
in the measures of pain-related distress and a slightly smaller change in physical function. 
The change in direction of the coefficients (negative direct and total effects for all sensitivity 
analysis) could also be indicative of a larger change in the control group when all available 
data were used. Non-response analysis indicated there were baseline differences between 
responders and non-responders at four-month follow-up, with responders being older, less 
disabled, and having lower scores for fear-avoidance beliefs, catastrophising, and 
depression. 
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Discussion 
The STarT Back trial was originally designed to test whether a model of stratified care 
consisting of targeted treatment matched to prognostic subgroups would lead to improved 
patient outcomes compared to best current primary care for back pain. The aim of the 
present study was to test the hypothesis that the observed favourable outcomes of the 
stratified intervention in the STarT Back high-risk group were mediated by changes in pain-
related distress and pain intensity.  
 
The preliminary analyses demonstrated that residualised change in four of the psychological 
variables used in the STarT Back trial and pain intensity met the criteria for potential 
mediation of treatment outcome. The mediation model confirmed the study hypothesis, 
with residualised change in both pain-related distress and pain intensity being found to be 
mediators of the relationship between treatment group allocation and residualised change 
in disability.  
 
Comparison with conceptual model 
When evaluating mediation models, it has been proposed that the paths can be split into 
action theory (a path) and conceptual theory (b path) [6,7]. Action theory is described as the 
intervention’s power to detect the potential mediator while conceptual theory is described 
as the potential mediator’s power to detect the outcome [7]. It has been suggested that 
these two elements form the theoretical basis between the two paths [46]. If the 
association between the intervention and the potential mediator is weak, this suggests that 
the action theory has failed; the intervention is not doing enough to affect the mediator [7]. 
If the association between the potential mediator and the outcome is weak, then the 
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conceptual theory has failed; the intervention is targeting the wrong factors for change [7], 
meaning that the underlying theory is wrong. In the present analysis, this interpretation 
would suggest that the stronger associations between change in the mediators and change 
in disability (conceptual theory) show that targeting pain-related distress and pain intensity 
was important, but the weaker associations between treatment allocation and change in 
the mediators (action theory) suggest that the psychologically informed physiotherapy did 
not greatly influence these factors. This possibly reflects the fact that this treatment, 
although targeting psychological factors, did not target them as specifically or effectively as 
a more intensive treatment delivered by psychologists, such as CBT. This could also be 
because change occurred in both the treatment and control groups, with the magnitude of 
this change sometimes being larger in the control group. Pain-related distress is only one of 
many potential mediators that could be explaining the treatment effect seen in the high-risk 
patients in the trial, and it is likely that other, unmeasured variables could have a stronger 
association with outcome, especially in the treatment group. 
 
The alternative pathway to treatment outcome, through a change in low back pain intensity, 
was found to be a stronger mediator of the relationship between the high-risk treatment 
and disability than change in pain-related distress. The two latent variables of pain-related 
distress and low back pain were found to have a strong relationship with each other. 
However, change in the variables was analysed as occurring in parallel rather than testing 
whether improvement in one leads to improvement in the other. The focus of this study was 
to test whether the trial authors’ theory of how the trial worked was correct rather than 
test a more complex model of multiple mediating factors. The goodness-of-fit statistics 
provided for the mediation model presented above did not all meet the criteria for good fit, 
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indicating that the hypothesised pathways may not be the only explanation for the effect of 
treatment on change in disability. Future research could test a more complicated model 
which includes multiple potential mediators in a single pathway, to show a process of 
change in several variables as part of the treatment process. This would also allow testing of 
other variables that might be important in leading to a change in outcome, such as 
treatment expectations, that may help to further explain how the treatment worked. 
 
Comparison with previous findings 
Few studies of treatment mediation in MSK pain populations have been conducted to date 
[32]. This analysis therefore adds important information to the current evidence base. Two 
previous studies of treatment mediation in primary care LBP populations [43,45] have also 
found evidence for psychological factors being mediators of treatment effect, but these 
studies used more intensive, CBT-based therapies. The STarT Back intervention was 
deliberately designed to be a less intensive “light-touch” therapy that could still address 
psychological factors. The studies also used different methods of mediation analysis and did 
not include latent variables, making it difficult to compare their results with those found in 
the present analysis.  
 
Potential limitations 
The FIML (sensitivity) analysis and non-response analysis suggested that the participants 
included in the complete case analysis differed substantially from those who were excluded, 
indicating high risk of attrition bias. This was particularly apparent in the psychological 
measures, where responders at four-month follow-up, particularly in the control group, had 
lower baseline scores of fear-avoidance beliefs, catastrophising and depression compared to 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
non-responders. This means that the results presented above need to be interpreted with 
caution, as they represent only a selective subsample of the high-risk population included in 
the trial.  
 
Pain duration was not accounted for in this mediation analysis. Different levels of pain 
duration may have affected patients in different ways; patients with new pain episodes are 
likely to have lower levels of catastrophising thoughts or fear-avoidance beliefs, while 
patients with persistent pain may have higher levels of distress. One way of testing this 
would be to carry out a moderated mediation analysis (e.g. [2]). However, it was felt that 
subgrouping patients further when already looking only at the high-risk subgroup would 
have affected the reliability and robustness of the analysis.  
 
Temporality, or the order in which change occurred, is a major issue in mediation analysis as 
all mediation models, regardless of analysis method used, assume a causal order to the 
variables. However, this causal order is rarely tested as studies often do not take enough 
assessments of the mediator and outcome to establish which of the variables changed first. 
The current study analysed the association of change between the mediator and outcome 
variables at the same time-points, and it is therefore possible that a reduction in disability 
could have led to a reduction in pain-related distress, rather than change in distress leading 
to a change in disability as hypothesised in the present analysis. Additional measurements 
of all variables of interest would therefore help to establish when change occurs and the 
order in which it occurs [24,26]. The STarT Back study did collect data at a long-term follow-
up point (12 months), meaning that this time point could have been potentially used in the 
analysis to look at change in outcome over a longer time period. However, the aim of this 
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mediation analysis was to investigate what could have been responsible for the effect of the 
intervention on outcome, and looking at change over a longer period of time may mean that 
other, external factors could have impacted on change in the outcome. This further 
highlights the issue of when measures should be taken in order to map the mediating 
pathway. 
 
It should be noted that the two latent variables of pain intensity and pain-related distress 
were highly correlated, suggesting that multicollinearity may be an issue in this analysis. This 
was acknowledged in the SEM by allowing the two constructs to co-vary. Pain and distress 
are closely interlinked and we felt separating the two concepts or looking at them in 
isolation would not provide an adequate test of the study hypothesis. 
 
Clinical implications 
Exploring mediators of treatment effect has important implications for clinical practice in 
that identifying the key factors that lead to improved outcomes will help lead to more 
focused interventions by providing information on the parts of treatment that are key to 
changing outcome. This is important as many interventions for LBP are multifaceted and it is 
unclear which of the different treatment components are necessary for patients to improve. 
While this analysis investigates a broad psychological factor, future studies could investigate 
more specific factors in a more focused intervention, or other modifiable, non-psychological 
factors deemed important in the process of change in outcome. More streamlined 
treatments may reduce the number or length of treatment sessions needed, thereby also 
reducing treatment costs. This study represents a first step in this process, and more 
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evidence is required in order for factors to be more definitively found to be on the causal 
pathway. 
 
Conclusion 
The psychological variables that physiotherapists aimed to address during the STarT Back 
high-risk intervention explained a significant proportion of the treatment effects observed in 
the trial. The mediation analysis conducted represents a robust analysis of potential 
treatment mediators and emphasises the importance for intervention studies to be 
underpinned by a clear theoretical or conceptual model. However, this analysis only looked 
at change between two time points which was not enough to assess the temporal order of 
the variables in the model. Trials that are designed to adequately test for mediating effects, 
with variables being measured at appropriate time points during treatment, are required in 
order to provide stronger evidence of treatment mediation. 
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Table 1 Baseline means and SDs and mean change at four-month follow-up for potential 
mediator variables in the STarT Back dataset high-risk group 
 
 
 
Table 2 Univariable associations of changes in each potential mediator with change in 
functional outcomes in STarT Back participants: Linear regression analyses 
 
 
 
Table 3 Univariable associations of change in treatment allocation with change in each 
potential mediator: Linear regression analyses 
 
 
 
Figure 1 Full SEM model for mediating effect of changes in pain-related distress and pain 
intensity on change in disability: High-risk group 
 
 
 
 
Table 4 Total, direct and indirect effects of the mediation model on change in disability for 
high-risk patients 
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Table 1. Baseline means and SDs and mean change at four-month follow-up for potential 
mediator variables in the STarT Back dataset high-risk group 
 Baseline Score (Mean and SD) 
 
Four-month follow-up (Mean 
change and SD) 
High-risk 
treatment group 
(n=93) 
High-risk 
control group 
(n=45) 
High-risk 
treatment 
group 
(n=93) 
High-risk 
control group 
(n=45) 
Outcome 
Disability 14.41 (4.31) 14.07 (4.88) 7.49 (6.48) 3.62 (4.38) 
Potential Mediators 
Catastrophising 
thoughts 
25.24 (10.49) 25.88 (10.54) 11.07 (12.95) 6.64 (10.26) 
Fear-avoidance beliefs 46.21 (5.17) 45.52 (5.85) 9.24 (7.56) 3.40 (4.68) 
Anxiety 10.01 (4.39) 10.31 (3.59) 3.39 (4.10) 2.49 (3.95) 
Depression 8.77 (4.34) 8.40 (3.70) 3.55 (4.05) 1.69 (3.55) 
Pain 
Intensity 
Least 6.16 (2.58) 5.96 (3.25) 2.98 (2.87) 1.76 (3.19) 
Average 7.72 (2.12) 8.18 (1.80) 3.90 (3.24) 2.56 (2.62) 
Current 6.40 (2.33) 6.51 (2.64) 3.00 (2.88) 1.62 (3.00) 
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Table 2 Univariable associations of changes in each potential mediator with change in 
functional outcomes in STarT Back participants: Linear regression analyses 
Outcome Predictor Treatment 
Allocation 
Change at four-month follow-up 
Unstandardised 
B (SE) 
95% CI Standardised 
β  
R-square 
change 
RMDQ
∆
 Catastrophising 
thoughts
∆
 
Treatment 
(n=93) 
0.49 (0.09) 0.31 to 
0.67 
0.50 0.25 
Fear-avoidance beliefs
∆
 0.57 (0.09) 0.40 to 
0.74 
0.57 0.33 
Anxiety
∆
 0.59 (0.09) 0.40 to 
0.77 
0.56 0.31 
Depression
∆
 0.66 (0.09) 0.48 to 
0.83 
0.62 0.39 
Least pain
∆
 0.77 (0.08) 0.62 to 
0.93 
0.72 0.51 
Average pain
∆
 0.77 (0.07) 0.63 to 
0.91 
0.74 0.55 
Current pain
∆
 0.84 (0.07) 0.71 to 
0.98 
0.80 0.63 
Catastrophising 
thoughts
∆
 
Control 
(n=45) 
0.58 (0.11) 0.37 to 
0.80 
0.64 0.41 
Fear-avoidance beliefs
∆
 0.73 (0.12) 0.05 to 
0.97 
0.67 0.45 
Anxiety
∆
 0.46 (0.10) 0.27 to 
0.65 
0.59 0.35 
Depression
∆
 0.58 (0.09) 0.40 to 
0.75 
0.71 0.50 
Least pain
∆
 0.45 (0.10) 0.26 to 
0.65 
0.59 0.34 
Average pain
∆
 0.50 (0.11) 0.28 to 
0.72 
0.57 0.32 
Current pain
∆
 0.47 (0.10) 0.27 to 
0.68 
0.58 0.34 
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Table 3 Univariable associations of change in treatment allocation with change in each 
potential mediator: Linear regression analyses 
Outcome Predictor Unstandardised 
B (SE) 
 
95% CI Standardised 
β  
R-square 
change 
Catastrophising 
thoughts
∆
 
Treatment 
Allocation 
0.41 (0.18) 0.06 to 0.76 0.19 0.04 
Fear-avoidance 
beliefs
∆
 
Treatment 
Allocation 
0.72 (0.17) 0.39 to 1.06 0.34 0.12 
Anxiety
∆
 Treatment 
Allocation 
0.28 (0.18) -0.08 to 
0.63 
0.13 0.02 
Depression
∆
 Treatment 
Allocation 
0.47 (0.18) 0.12 to 0.82 0.22 0.05 
Least pain
∆
 Treatment 
Allocation 
0.44 (0.18) 0.08 to 0.79 0.21 0.04 
Average pain
∆
 Treatment 
Allocation 
0.58 (0.18) 0.23 to 0.92 0.27 0.07 
Current pain
∆
 Treatment 
Allocation 
0.52 (0.18) 0.17 to 0.87 0.25 0.06 
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Table 4 Total, direct and indirect effects of the mediation model on change in disability for 
high-risk patients 
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% 
CI) 
RMDQ
∆
 Total (ć) 0.30 (0.14 to 0.43) 0.63 (0.29 to 0.94) 
Direct (c) 0.05 (-0.05 to 0.16) 0.11 (-0.11 to 0.33) 
Indirect (ab) 0.25 (0.09 to 0.39) 0.52 (0.19 to 0.85) 
∆
residualised change 
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Figure 1 Full SEM model for mediating effect of changes in pain-related distress and pain 
intensity on change in disability: High-risk group 
 
 
 
 
 
 
 
 
 
∆
residualised change 
*p<0.05 
**p<0.01 
 
All values are standardised 
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∆
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